Shares of pharmaceutical companies declined after U.S. President Donald Trump announced plans to lower U.S. prescription drug ...

Shares of pharmaceutical companies fell across Europe and Asia after President Donald Trump said he planned to order a cut in ...

President Donald Trump said he plans to order a cut in US prescription drug costs by mandating that Americans pay no more ...

Takeda Pharmaceuticals delivered strong FY2024 results and offers value with a 4.81% yield, despite pressure from Vyvanse ...

China’s exports surged as shipments to Southeast Asian countries soared, offsetting a sharp drop in outbound goods to the U.S ...

Kroger, Albertsons and others allege an unlawful monopoly in one legal case and aim to recover overcharges for a drug in ...

Takeda Pharmaceutical Co. (TAK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Takeda will host an investor call on Sunday ... but it is to illustrate that as a global innovative pharmaceutical company, we have a very strong presence in the U.S., which is, by far today ...

Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US ...

Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US ...

The U.S. president's social media post put pressure on drug-related stocks on worries their profits will take a hit if they ...

He plans to sign an executive order to cut prescription drug prices. Read more at straitstimes.com. Read more at straitstimes ...